Theravance Biopharma
TBPH
#6136
Rank
$0.43 B
Marketcap
Cayman Islands
Country
$8.99
Share price
-1.43%
Change (1 day)
-18.35%
Change (1 year)
Categories
Theravance Biopharma (TBPH) - Cash on Hand
Cash on Hand as of December 2023 : $0.10 B
According to Theravance Biopharma
's latest financial reports the company has $0.10 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Theravance Biopharma - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.10 B | -68.72% |
| 2022-12-31 | $0.32 B | 88.79% |
| 2021-12-31 | $0.17 B | -40.79% |
| 2020-12-31 | $0.29 B | 4.31% |
| 2019-12-31 | $0.28 B | -44.42% |
| 2018-12-31 | $0.50 B | 44.96% |
| 2017-12-31 | $0.34 B | -30.44% |
| 2016-12-31 | $0.50 B | 190.6% |
| 2015-12-31 | $0.17 B | -32.28% |
| 2014-12-31 | $0.25 B | |
| 2013-12-31 | $N/A |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Corcept Therapeutics
CORT | $0.36 B | 259.50% | 🇺🇸 USA |
 Collegium Pharmaceutical
COLL | $0.31 B | 203.19% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $0.13 B | 34.38% | 🇺🇸 USA |
 Catalent CTLT | $0.22 B | 123.58% | 🇺🇸 USA |